High-dose therapy in breast cancer: Out of favor but not out of promise

S. Glück, D. Stewart

Research output: Contribution to journalEditorial

8 Scopus citations

Abstract

The evidence for use of high-dose chemotherapy and autologous stem cell transplantation for breast cancer still remains inconclusive at best. A number of prospective randomized phase III studies have been either published or presented recently or are underway in North America and Europe. It will be crucial to complete the available prospective randomized phase III study and obtain the data when all studies reach a mature status. Only then will level I evidence become available to determine the efficacy and effectiveness of high-dose chemotherapy and autologous stem cell transplantation in breast cancer.

Original languageEnglish (US)
Pages (from-to)1017-1019
Number of pages3
JournalBone Marrow Transplantation
Volume25
Issue number10
DOIs
StatePublished - Jan 1 2000

Keywords

  • Breast cancer
  • Controversy
  • Evidence for efficacy
  • High-dose chemotherapy

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'High-dose therapy in breast cancer: Out of favor but not out of promise'. Together they form a unique fingerprint.

  • Cite this